Advertisement
Home Tags Cancer: Prostate

Tag: Cancer: Prostate

Eating a low-fat meal when taking an expensive prostate cancer drug can cut the cost of the medication by three-quarters

ASCO: Taking Abiraterone Acetate With Low-Fat Meal Can Cut Cost

0
Research indicates high-fat meals raise levels of the drug more unpredictably
When prostate cancer recurs after surgery

Bicalutamide Improves Survival After Prostate Cancer Returns

0
Fewer bicalutamide patients died of prostate cancer compared to patients taking placebo
For men with distant

Superior Survival for Asian Men With Prostate Cancer

0
Superior median overall survival and prostate cancer-specific mortality in de novo metastatic PCa
For men with high serum prostate-specific antigen

Multi-Parametric MRI Shows Benefit As Triage Test

0
Research shows MP-MRI could reduce unnecessary prostate biopsies
Placement of a retropubic urethral sling fashioned from autologous vas deferens during robotic assisted radical prostatectomy does not improve recovery of continence

Autologous Urethral Sling No Benefit After Prostatectomy

0
No benefit seen in continence for sling placement during robotic assisted radical prostatectomy
A novel video intervention can alter the screening intentions of a target audience

Video Intervention Persuasive for Screening Recommendations

0
Intervention changed screening intentions of substantial proportion of male, female viewers
Use of zoledronic acid every 12 weeks does not result in increased risk of skeletal events compared with use every four weeks among patients with bone metastases due to breast cancer

Zoledronic Acid Every 12 Weeks Noninferior in Bone Metastases

0
No increase in risk of skeletal events versus treatment every four weeks for bone metastases
Certain patients on active surveillance for prostate cancer may be eligible for less intensive surveillance

Less Intense Surveillance OK for Some Prostate Cancer Cases

0
Patients on active surveillance with stable disease may be candidates for less intense surveillance
The rate of germline BRCA1/2 and ATM mutations is significantly higher among patients with lethal prostate cancer and is an independent predictor of lethal prostate cancer

BRCA1/2, ATM Mutations ID Risk for Lethal Prostate Cancer

0
After adjustment for covariates, mutation carrier remained independent predictor of lethal PCa
Magnetic resonance imaging (MRI) and MRI-targeted biopsies have a role in the diagnosis and treatment of patients with a prior negative prostate biopsy

MRI Has a Role to Play After Negative Prostate Biopsy

0
Magnetic resonance imaging, MRI-targeted biopsy facilitate detection of clinically significant disease